New flu shot for seniors enters first human safety tests
NCT ID NCT07302256
Summary
This study is testing the safety and immune response of a new influenza (flu) vaccine in healthy adults aged 60 and older. It will enroll 120 participants to receive either the new vaccine, an existing vaccine, or a placebo shot. The main goal is to see how safe the new vaccine is and if it triggers a good immune response against the flu virus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Danjiangkou Disease Prevention and Control Center
RECRUITINGWuhan, Hubei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.